Research on Her2 and CXCR4 Bispecific Antibodies

f1
Xu, C., Zhao, H., Chen, H., & Yao, Q. (2015). CXCR4 in breast cancer: oncogenic role and therapeutic targeting. Drug design, development and therapy, 9, 4953.

  • Aimed to design a novel bispecific antibody to treat breast cancer.
  • Independently screened the strain, did the transformation, and plasmid transfection, determined the antibody Kd value.